DBVT logo

DBV Technologies SA (DBVT)

Profile

Full Name

DBV Technologies S.A.

Ticker Symbol

DBVT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

October 22, 2014

Indexes

Not included

Website

http://www.dbv-technologies.com

Employees

109

Key Details

Price

$8.52(-2.63%)

Market cap

$232.91M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$5.85(-53.95% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$8.52
DBVT price is $8.52

30-Day Relative Volume

1.10
DBVT 30-day relative volume is 1.10

Price Performance

Price Today change

-2.63%
DBVT price is down -2.63% today

Price YTD change

+175.73%
DBVT price is up +175.73% since January 1st

Price 1-year change

+526.48%
DBVT price is up +526.48% year-on-year

Price 3-year change

+208.7%
DBVT price is up +208.7% over the past 3 years

Price Range

Price All-time high

$101.14
DBVT price is currently -91.58% below its historical high of $101.14

Price 3-year low

$0.44
DBVT price is currently +1832.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$232.91M
DBVT market capitalization is $232.91 million

Market cap 3-year change

+667.83%
DBVT market capitalization is up +667.83% over the past 3 years

Market cap All-time high

$487.75M
DBVT market capitalization is currently -52.25% below its historical high of $487.75 million

Market cap sector rank

57.86%
DBVT market capitalization is higher than 57.86% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+41.74%
DBVT shares outstanding is up +41.74% year-on-year

Shares Outstanding 3-Year Change

+148.73%
DBVT shares outstanding is up +148.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.62
DBVT beta is 0.62

200-day SMA

$2.68
DBVT price is currently +218.26% above its 200-day simple moving average

50-day SMA

$5.43
DBVT price is currently +56.82% above its 50-day simple moving average

RSI

67.89
DBVT 14-day relative strength index is 67.89

Volume

1.10
DBVT 30-day relative volume is 1.10

ATR

$0.80
DBVT average true range is $0.80

10-day Historical Volatility

85.81%
DBVT 10-day historical volatility is 85.81%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
DBVT annual revenue value is unknown

Revenue Analysts estimate

$1.85M
DBVT annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
DBVT annual revenue 1-year change is unknown

Revenue Sector rank

-
DBVT annual revenue is unknown

EPS

EPS

-$5.85
DBVT annual earnings per share is -$5.85

EPS Analysts estimate

-$0.94
DBVT annual earnings per share is currently +519.70% higher than the consensus analysts' forecast

EPS 1-year change

-53.95%
DBVT annual earnings per share is down -53.95% year-on-year

EPS Sector rank

16.71%
DBVT annual earnings per share is higher than 16.71% of companies in Healthcare sector

Profit

Gross profit

-
DBVT annual gross profit value is unknown

Gross margin

-
DBVT annual gross profit margin value is unknown

Operating profit

-$116.50M
DBVT annual operating income is -$116.50 million

Operating margin

-
DBVT annual operating profit margin value is unknown

Net income

-$113.92M
DBVT annual net profit is -$113.92 million

Net margin

-
DBVT annual net profit margin value is unknown

Expenses

Total expenses

$116.50M
DBVT annual total expenses is $116.50 million

Operating expenses

$116.50M
DBVT annual total operating expenses is $116.50 million

Cost of goods sold

-
DBVT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$31.40M
DBVT annual SGA is $31.40 million

Depreciation and amortization

-$925.00K
DBVT annual depreciation & amortization is -$925.00 thousand

Interest expense

-
DBVT annual interest expense value is unknown

Income tax

$100.00K
DBVT annual income tax is $100.00 thousand

EBIT & EBITDA

EBIT

-$116.50M
DBVT annual earnings before interest & taxes is -$116.50 million

EBITDA

-$116.50M
DBVT annual EBITDA is -$116.50 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$65.66M
DBVT annual total assets is $65.66 million

Non current assets

$33.20M
DBVT annual long term assets is $33.20 million

Current assets

$32.50M
DBVT annual total current assets is $32.50 million

Cash and cash equivalents

$32.50M
DBVT annual cash & cash equivalents is $32.50 million

Accounts receivable

-
DBVT annual accounts receivable value is unknown

Inventory

-
DBVT annual inventory value is unknown

Liabilities

Total liabilities

$38.27M
DBVT annual total liabilities is $38.27 million

Long term liabilities

$7.13M
DBVT annual total long term liabilities is $7.13 million

Current liabilities

$31.14M
DBVT annual total current liabilities is $31.14 million

Accounts payable

$22.03M
DBVT annual accounts payable is $22.03 million

Debt

Total debt

$7.80M
DBVT annual total debt is $7.80 million

Total debt 1-year change

+18.98%
DBVT annual total debt is up +18.98% year-on-year

Long term debt

$6.30M
DBVT annual long term debt is $6.30 million

Short term debt

$1.50M
DBVT annual short term debt is $1.50 million

Equity & Capital

Shareholders equity

$27.39M
DBVT annual stockholders equity is $27.39 million

Book value

$27.40M
DBVT annual book value is $27.40 million

Retained earnings

-$286.38M
DBVT annual retained earnings is -$286.38 million

Working capital

$1.36M
DBVT annual working capital is $1.36 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$104.50M
DBVT annual cash flow from operations is -$104.50 million

Cash from operations 1-year change

-31.19%
DBVT annual cash flow from operations is down -31.19% year-on-year

Cash from investing

-$800.00K
DBVT annual cash flow from investing activities is -$800.00 thousand

Cash from investing 1-year change

+0.99%
DBVT annual cash flow from investing activities is up +0.99% year-on-year

Cash from financing

$600.00K
DBVT annual cash flow from financing activities is $600.00 thousand

Cash from financing 1-year change

-91.13%
DBVT annual cash flow from financing activities is down -91.13% year-on-year

CAPEX

CAPEX

-
DBVT annual capital expenditures value is unknown

CAPEX 1-year change

-
DBVT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$104.50M
DBVT annual free cash flow is -$104.50 million

Free cash flow 1-year change

-30.09%
DBVT annual free cash flow is down -30.09% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
DBVT annual gross profit margin value is unknown

Operating margin

-
DBVT annual operating profit margin value is unknown

Net margin

-
DBVT annual net profit margin value is unknown

ROA & ROE

ROA

-173.50%
DBVT annual return on assets is -173.50%

ROE

-415.94%
DBVT annual return on equity is -415.94%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DBVT price to earnings ratio value is unknown

PE ratio Sector rank

-
DBVT price to earnings ratio is unknown

PB Ratio

PB ratio

8.50
DBVT price to book ratio is 8.50

PB ratio Sector rank

90.3%
DBVT price to book ratio is higher than 90.3% of companies in Healthcare sector

PS Ratio

PS ratio

-
DBVT price to sales ratio value is unknown

PS ratio Sector rank

-
DBVT price to sales ratio is unknown

Enterprise value

Enterprise value

$208.25M
DBVT enterprise value is $208.25 million

Enterprise value Sector rank

57.62%
DBVT enterprise value is higher than 57.62% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.91
DBVT EV/EBITDA is -1.91

EV/EBITDA Sector rank

35.38%
DBVT EV/EBITDA is higher than 35.38% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.04
DBVT annual current ratio is 1.04

Quick ratio

-
DBVT annual quick ratio value is unknown

Leverage

Debt to equity

0.28
DBVT annual debt to equity ratio is 0.28

Interest coverage ratio

-
DBVT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
DBVT piotroski f-score value is unknown

Altman Z-Score

-
DBVT altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 4, 25 Citizens Capital Markets
Market Outperform
Jan 10, 25 JMP Securities
Market Outperform
Dec 10, 24 JMP Securities
Market Outperform
Oct 24, 24 HC Wainwright & Co.
Buy
Aug 1, 24 HC Wainwright & Co.
Buy
Jul 31, 24 JMP Securities
Market Outperform
May 8, 24 HC Wainwright & Co.
Buy
Feb 21, 24 HC Wainwright & Co.
Buy
Nov 13, 23 HC Wainwright & Co.
Buy
Nov 2, 23 Goldman Sachs
Sell

Institutional Ownership

Similar stocks

TOI logo
Oncology Institute (TOI)
CDTX logo
Cidara Therapeutics (CDTX)
DRUG logo
Bright Minds Biosciences (DRUG)
FHTX logo
Foghorn Therapeutics (FHTX)
Acelyrin (SLRN)
TERN logo
Terns Pharmaceuticals (TERN)
ACB logo
Aurora Cannabis (ACB)
NRC logo
National Research (NRC)
AVIR logo
Atea Pharmaceuticals (AVIR)
  • What is the ticker symbol for DBV Technologies SA?
  • Does DBV Technologies SA pay dividends?
  • What sector is DBV Technologies SA in?
  • What industry is DBV Technologies SA in?
  • What country is DBV Technologies SA based in?
  • When did DBV Technologies SA go public?
  • Is DBV Technologies SA in the S&P 500?
  • Is DBV Technologies SA in the NASDAQ 100?
  • Is DBV Technologies SA in the Dow Jones?
  • When was DBV Technologies SA's last earnings report?
  • When does DBV Technologies SA report earnings?
  • Should I buy DBV Technologies SA stock now?

What is the ticker symbol for DBV Technologies SA?

The ticker symbol for DBV Technologies SA is NASDAQ:DBVT

Does DBV Technologies SA pay dividends?

No, DBV Technologies SA does not pay dividends

What sector is DBV Technologies SA in?

DBV Technologies SA is in the Healthcare sector

What industry is DBV Technologies SA in?

DBV Technologies SA is in the Biotechnology industry

What country is DBV Technologies SA based in?

DBV Technologies SA is headquartered in France

When did DBV Technologies SA go public?

DBV Technologies SA's initial public offering (IPO) was on October 22, 2014

Is DBV Technologies SA in the S&P 500?

No, DBV Technologies SA is not included in the S&P 500 index

Is DBV Technologies SA in the NASDAQ 100?

No, DBV Technologies SA is not included in the NASDAQ 100 index

Is DBV Technologies SA in the Dow Jones?

No, DBV Technologies SA is not included in the Dow Jones index

When was DBV Technologies SA's last earnings report?

DBV Technologies SA's most recent earnings report was on Mar 24, 2025

When does DBV Technologies SA report earnings?

The next expected earnings date for DBV Technologies SA is May 7, 2025

Should I buy DBV Technologies SA stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page